Cellipont Bioservices is a privately held cell therapy CDMO with more than 15 years experience in the development and small-to-large batch manufacturing of cell therapies. Our team is very strong technically and has been recognized by customers and technology partners for its ability to productively grow challenging cells. Our team is driven to help our clients to expand patient access to life-changing medicines. We are a small company with a culture that is extremely responsive and customer-centric. Despite our size, Cellipont has very deep technical experience, including 18,000+ tissue samples and more than 900 primary cell cultures.